Despite the implementation of programmes to improve maternal health, maternal and foetal mortality rates still remain high. The presence of maternal distress and its association with the development of pregnancy hypertensive disorders...
Poor-quality care during institutional births in low- and middle-income countries is a major contributing factor to preventable maternal and newborn...
We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.
Pre-eclampsia is a complex disease with significant maternal and fetal morbidity and mortality. Its syndromic nature makes diagnosis and management difficult. The field is rapidly evolving with the definition of pre-eclampsia being...
This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth.
Cardiac shock is the leading cause of death in patients with acute myocardial infarction.
Adults Yemex is indicated for management of severe chronic pain that requires continuous long-term opioid administration. Children Long-term management of severe chronic pain in children from 2 years of age who are receiving opioid therapy.
Adults Mezolar Matrix is indicated for management of severe chronic pain that requires continuous long-term opioid administration. Children Long-term management of severe chronic pain in children from 2 years of age who are receiving opioid therapy.
This guideline covers the care of healthy women and their babies, during labour and immediately after the birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’).
Adults This product is indicated for management of severe chronic pain that requires continuous long term opioid administration. Children Long term management of severe chronic pain in children receiving opioid therapy from 2 years of age.